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Cardiac Allograft Involvement by
Post-Transplantation Lymphoproliferative Disorder
Katarina H. Nelson, MD,* Yiannis S. Chatzizisis, MD, PHD,y Michael L. Steigner, MD,*
Richard N. Mitchell, MD, PHD,z Ron Blankstein, MD,*y Michael M. Givertz, MDy
Boston, Massachusetts26-year-old man with a history of Becker’s muscular dystrophy and cardiomyopathy,A3years status post cardiac transplantation, presented with rapidly worsening heart failure.Transthoracic echocardiography showed moderate biventricular dysfunction with global
hypokinesis and 4-chamber dilation (A, Online Video 1). Cardiac magnetic resonance showed
interventricular septal edema on T2-weighted imaging (B) and extensive midwall late gadolinium
enhancement involving both ventricles and atria, as well as the pericardium (C,D). The differential
diagnosis included post-transplantation lymphoproliferative disorder, myopericarditis, and, less
likely, cardiac sarcoidosis. Right ventricular endomyocardial biopsy showed multifocal plasmacy-
toid inﬁltration (E) and excluded acute cellular rejection. Immunohistochemical studies demon-
strated monoclonal kappa in situ hybridization and negative ribonucleic acid for Epstein-Barr
virus (F,G). Collectively, the biopsy and cardiac magnetic resonance ﬁndings were most
consistent with post-transplantation lymphoproliferative disorder. There was no evidence of
18F-ﬂuorodeoxyglucose-avid disseminated lymphoproliferative process on positron emission
tomography (H). After reduction of immunosuppressive medications, the patient was treated
with monoclonal anti-CD20 antibody (rituximab) and bendamustine.
